Mimedx (MDXG) Current Taxes (2015 - 2017)

Mimedx (MDXG) posted Current Taxes of $2.3 million for Q3 2017, up 383.33% sequentially from -$822000.0 in Q2 2017.

Mimedx (MDXG) Current Taxes (2015 - 2017) Analysis & Trends

Mimedx has reported Current Taxes for 3 years, with the latest figure at $2.3 million in Q3 2017.

Quarterly Current Taxes changed N/A year-over-year to $2.3 million in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $2.3 million (changed N/A YoY) and the FY2016 annual result came in at $5.6 million, up 8474.63% from the prior year.
Current Taxes climbed to $2.3 million in Q3 2017 per MDXG's latest filing, from -$822000.0 in the prior quarter.
Over five years, Current Taxes peaked at $7.8 million in Q1 2017 and troughed at -$822000.0 in Q2 2017.
A 3-year average of $3.0 million and a median of $2.3 million in 2017 frame the typical range for Current Taxes.
The widest YoY moves for Current Taxes: up 8474.63% in 2016, down 8474.63% in 2016.
Over 3 years, Current Taxes stood at -$67000.0 in 2015, then surged by 8474.63% to $5.6 million in 2016, then slumped by 58.49% to $2.3 million in 2017.
According to Business Quant data, Current Taxes over the past three periods registered $2.3 million, -$822000.0, and $7.8 million for Q3 2017, Q2 2017, and Q1 2017 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Mimedx	622.24 Mn	486.40 Mn	44.38 Mn	-

Download Data